|
Human Genome reports widened losses
BOSTON April 27, 2005 - Human Genome Sciences reported widened
quarterly losses on Wednesday which it attributed to a decrease in interest
income and an increase in research spending.
For the quarter ended March 31, Human Genome (HGSI) posted a net loss of
$59.6 million, or 46 cents a share, compared with a net loss of $55.4
million, or 43 cents a share, for the same period last year.
Revenue for the quarter was $1.1 million, compared with $1.6 million last
year, which included a significant milestone payment from GlaxoSmithKline.
Click here for full article.
|
|
